1. Expression of the antisense cDNA for protein kinase C-α attenuates resistance in doxorubicin-resistant MCF-7 breast carcinoma cells;Ahmad;Mol. Pharmac.,1993
2. Antitumor activity of UCN-01, a selective inhibitor of protein kinase C, in murine and human tumor models;Akinaga;Cancer Res.,1991
3. Enhancement of antitumour activity of mitomycin C in vitro and in vivo by UCN-01, a selective inhibitor of protein kinase C;Akinaga;Cancer Chemother. Pharmac.,1993
4. G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells;Akiyama;Cancer Res.,1997
5. The protein kinase C inhibitors RO 31 8220 and GF 109203X are equally potent inhibitors of MAPKAP kinase-1β (Rsk-2) and p70 S6 kinase;Alessi;FEBS Lett.,1997